Discussion: The Role, Position, and Function of the FDA—The Past, Present, and Future
Open accessAbstract
The health of the nation and the world has been profoundly positively influenced by the pursuit and implementation of evidence-based approaches for the prevention and treatment of diseases. The US Food and Drug Administration (FDA), along with other regulatory authorities throughout the world, have made critically important contributions to this pursuit. The FDA recognizes their mission is to be “responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation’s food supply, cosmetics, and products that emit radiation... FDA is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health.” The FDA has effectively addressed their mission by providing consistently strong leadership and oversight that has been of integral importance to protecting public health. The FDA has been highly influential in the attainment of substantial evidence of efficacy and safety of approved drugs, biologics and devices by ensuring achievement of proper standards for design, conduct and analysis of registrational trials. Among these significant favorable influences have been: ∼ Encouraging stepwise clinical development; ∼ Having pro…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The FDA plays a central role in regulating and ensuring the safety and effectiveness of drugs, biologics, and medical devices.
“The FDA plays a central role in regulating and ensuring the safety and effectiveness of various products, including drugs, biologics, and medical devices [323].”
From Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors (2026) · cites this paper as [323]
Cited by
Sorted by citations
Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors
Yen, C., Epling, J. W., Rockwell, M., & Vaughn-Cooke, M. (2026) · Diagnostics · doi:10.3390/diagnostics16020347 · Cited by 6 · see citing works
- Authors
- Fleming, T. R., Demets, D. L., & McShane, L. M.
- Affiliations
- University of Washington (US)
- University of Wisconsin–Madison (US)
- National Institutes of Health (US)
- Corresponding author
- Fleming, Thomas R.
- Venue
- Biostatistics
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-06-12
- Volume
- 18
- Issue
- 3
- Pages
- 417-421
- ISSN
- 1465-4644 (ISSN-L)
- 1468-4357
- PMC
- PMC5862299
- OpenAlex
- W2783136541
- Cited by
- 13
- References
- 0
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 3 · 2021: 2
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Biostatistics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Health Professions › Health Information Management › Healthcare Regulation
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmaceutical industry and healthcare
- Keywords
- US Food and Drug Administration, drug regulation, clinical trial design, evidence-based medicine, clinical trial endpoints, biomarkers, confirmatory trials, exploratory analysis, randomization, blinding, multiplicity, trial conduct, regulatory oversight, public health protection, medical devices, biologics, food safety
- MeSH terms
- Drug Development, Humans, United States, United States Food and Drug Administration, Conflict of Interest, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review